SCHMID Group has top-tier glass-substrate equipment, but heavy dilution and an unproven second half make it a stock to wait on. Its backlog was €49M at end-Q1 2026 and it is commercializing its Any Layer ET process for AI chip packaging, yet Q1 revenue was only €18.2M against reiterated FY guidance above €100M with adjusted EBITDA margin well above 12%. A €30.75M debt-for-equity swap and note conversions push shares past 57.8M. Until H2 delivery is evident, the stock likely stays under pressure. … Show more

Schmid Group's turnaround is real, but at $6.87 it carries mega-cap multiples for a sub-scale company with going-concern doubt and a dilution overhang. Fully diluted it trades at 6.5x EV/sales and 54x EV/EBITDA on the bull guide, with shares possibly rising from 43M to 102M, though that is a worst-case ceiling. Management missed its FY25 revenue guide by 7% and EBITDA margin by 6 points, and now guides FY26 to €100M+ at 12%. H2 2025 did deliver €50M at 35% gross margin. x.com  x.com  x.com 

IC substrates are Schmid's more relevant growth driver today because demand is already high and rising. Schmid customers Ibiden and Unimicron are expanding capacity with NVIDIA support; higher order intake supports the prospect of more equipment orders. Its balance sheet has improved, and the risk/reward looks attractive at current levels despite volatility. Glass substrates may take another one to two years to matter commercially. This is a personal assessment, not a buy recommendation. x.com  … Show more

Schmid Group is moments from dilution, with almost no room for error in its cash runway. That financial position is critical to any comparison of glass-substrate plays, even as a post the author replies to argues upstream suppliers gain pricing power after Intel's CFO called glass a margin headwind. x.com 

SCHMID Group's financials are too poor, and pilot-phase adoption does not offset that despite a small revenue increase. It may be worth another look later. x.com 

Schmid may finally have a path to fund growth with operating cash flow and cheap debt instead of new stock, while orders accelerate. Order intake reached €96.6M through August, with a record backlog near €90M and much of it flowing into 2027. Management says it is "pretty well financed", sees no need for new equity for at least six months and has Chinese debt at about 2.7%. It remains a high-risk turnaround: management must convert backlog, lift a 21.2% gross margin and generate cash. x.com 

Chemicals are an obvious, overlooked layer of the AI buildout, and most of the stocks have not moved yet. Entegris is the purity play inside TSMC's Arizona fab, where one contaminant can ruin a $30,000 package. MKS supplies specialty chemicals for advanced packaging, Rogers is an indirect play on optical transceivers and high-speed switches, and Element Solutions is the most direct advanced-packaging play, with organic growth the highest since COVID. Chemours belongs in the group too. x.com  … Show more

LPKF faces mostly lumpy, cancelable pilot-line revenue until 2029, while the market already prices in much of its glass substrate option. Volume demand for its glass equipment hinges on TSMC and NVIDIA choosing glass for CoPoS panel packaging; that wave lands around 2028-29 and could slip to end-2030 on warpage and yield issues. Absolics' and Semco's 2027 plans are qualification. The real signals are TSMC's CoPoS tool-vendor selection and an LPKF order above EUR 10M naming a Tier-1 customer. … Show more

SCHMID is the lone European name in AI substrate tooling, over 90% of which ships from Asia, and its plating and wet-process lines feed the advanced-packaging step every AI chip passes through. The June 9 Zhongshan campus deal nearly doubles its regional capacity. It is a speculative flyer only: revenue fell 38% y/y to about €67M, net debt is ~€83M against €4M cash, and losses exceed sales, yet it trades at 5.1x EV/sales. A dilutive raise before the ramp pays off is what kills it. x.com 

SUSS MicroTec is mispriced, with near 100% revenue exposure to leading-edge chip equipment yet EV/revenue multiples a third to a fifth of US semicap majors. About 70% of revenue comes from advanced packaging tools such as temporary and hybrid bonders and 30% from front-end photomask tools; some are monopolies, others hold majority share or are call options. In a big semicap cycle, margins rising from 5% to 25% matter more than 20% to 40%. Its weak 2026 outlook matched sell-side expectations. … Show more